Transcode Therapeutics RNAZ
NASDAQ RNAZ
$1.59 +0.05 (+2.91%)
As of: Oct 2, 2026 · 10:52 AM EDT

Transcode Therapeutics (RNAZ) Shares Outstanding (Diluted) (2020 - 2026)

Updated

Transcode Therapeutics (RNAZ) reported Shares Outstanding (Diluted) of 957,191 for Q2 2026, up 14.8% from 833,654 a year earlier and up 4.4% from the prior quarter.

Analysis

Transcode Therapeutics (RNAZ) Shares Outstanding (Diluted) (2020 - 2026) Analysis & Trends

For FY2025, Transcode Therapeutics posted Shares Outstanding (Diluted) of 689,713, up 93.7% from FY2024.

  • Shares Outstanding (Diluted) has a five-year compound annual growth rate of 150.3% (FY2020 to FY2025).
  • By year, Shares Outstanding (Diluted) came in at 356,115 in FY2024, 5,424 in FY2023 (-72.4%), 19,661 in FY2022 (+54.0%) and 12,765 in FY2021 (+81.7%).
  • The Q2 2026 figure ranks as the highest quarterly Shares Outstanding (Diluted) since Q1 2025.
  • Year over year, Shares Outstanding (Diluted) gained in five of the last six quarters, with growth averaging 118.1%.
  • The high point for year-over-year Shares Outstanding (Diluted) in five years was Q1 2024 (growth of 614.2%); the low point was Q1 2026 (a decline of 81.0%).
  • Per Business Quant data, the three quarters before Q2 2026 came in at 916,968 (Q1 2026), 689,713 (Q4 2025) and 833,683 (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Shares Outstanding (Dil.) (Qtr)
1 Johnson & Johnson 638.12 Bn 556.64 Bn 17.26 Bn 2.44 Bn
2 AbbVie 462.60 Bn 435.75 Bn 12.70 Bn 1.77 Bn
3 Merck 358.70 Bn 313.13 Bn 12.21 Bn 2.47 Bn
4 Novartis Ag 272.16 Bn 228.03 Bn 11.24 Bn 1.96 Bn
5 Astrazeneca 250.36 Bn 223.92 Bn 12.86 Bn 1.56 Bn
6 Amgen 227.87 Bn 183.27 Bn 7.24 Bn 544.00 Mn
7 Gilead Sciences 184.97 Bn 159.08 Bn 6.22 Bn 1.24 Bn
8 Pfizer 162.61 Bn 109.56 Bn 10.94 Bn 5.70 Bn
9 Vertex Pharmaceuticals 132.45 Bn 104.46 Bn 2.84 Bn 255.20 Mn
10 Transcode Therapeutics 1.70 Mn 1.70 Mn - 957,191.00
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 957,191.00
Mar 31, 2026 916,968.00
Dec 31, 2025 689,713.00
Sep 30, 2025 833,683.00
Jun 30, 2025 833,654.00
Mar 31, 2025 4.82 Mn
Dec 31, 2024 356,115.00
Sep 30, 2024 271,473.00
Jun 30, 2024 213,649.00
Mar 31, 2024 155,815.00
Dec 31, 2023 5,424.00
Sep 30, 2023 95,663.00
Jun 30, 2023 39,982.00
Mar 31, 2023 21,817.00
Dec 31, 2022 19,661.00
Sep 30, 2022 19,661.00
Jun 30, 2022 19,661.00
Mar 31, 2022 19,661.00
Dec 31, 2021 12,765.00
Sep 30, 2021 17,463.00
API Access

Transcode Therapeutics Shares Outstanding (Diluted) API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=shares-outstanding-diluted&ticker=RNAZ&period=max&api_key=YOUR_API_KEY